Mike Cola

1.6

1.6

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Avalo Therapeutics, Inc. (AVTX)

Transaction date 9 Jun 2020

Purchase

Price

144.37

Quantity 18,563 +16.5%

Value US$4,781,300

Aevi Genomic Medicine Inc (GNMX)

Transaction date 9 Jun 2020

Purchase

Price

410.53

Quantity 80,761 +15.4%

Value US$707,573

Phathom Pharmaceuticals Inc (PHAT)

Transaction date 29 Oct 2019

Purchase

Price

138.63

Quantity 71,616 -18.7%

Value US$1,657,688

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2020-06-11	2020-06-09	Avalo Therapeutics, Inc. (AVTX)	B Purchase	18,563 +16.5% 144.37 US$4,781,300	18,563 +16.5%	144.37	US$4,781,300
2020-06-11	2020-06-09	Aevi Genomic Medicine Inc (GNMX)	B Purchase	80,761 +15.4% 410.53 US$707,573	80,761 +15.4%	410.53	US$707,573
2022-02-18	2019-10-29	Phathom Pharmaceuticals Inc (PHAT)	B Purchase	71,616 -18.7% 138.63 US$1,657,688	71,616 -18.7%	138.63	US$1,657,688